Cargando…
Metabolic syndrome in schizophrenia: Differences between antipsychotic-naïve and treated patients
Metabolic syndrome (MetS) has been recognized as a risk factor for cardiovascular morbidity and mortality in general population and in patients with severe mental illnesses like schizophrenia. This paper reviews studies on MetS in schizophrenia and related psychotic disorders, and assesses the contr...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3746300/ https://www.ncbi.nlm.nih.gov/pubmed/23960422 http://dx.doi.org/10.4103/0976-500X.114596 |